IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2007;48:422-429.)
© 2007 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-0534
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Satofuka, S.
Right arrow Articles by Ishida, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Satofuka, S.
Right arrow Articles by Ishida, S.

Role of Nonproteolytically Activated Prorenin in Pathologic, but Not Physiologic, Retinal Neovascularization

Shingo Satofuka,1,2 Atsuhiro Ichihara,3 Norihiro Nagai,1,2,4 Takashi Koto,1,2 Hajime Shinoda,1,2 Kousuke Noda,2 Yoko Ozawa,1,2 Makoto Inoue,2 Kazuo Tsubota,2 Hiroshi Itoh,3 Yuichi Oike,1,4 and Susumu Ishida1,2

1From the Laboratory of Retinal Cell Biology and the 2Departments of Ophthalmology, 3Internal Medicine, and 4Cell Differentiation, Keio University School of Medicine, Tokyo, Japan.

PURPOSE. Recently, it was revealed that the inhibition of nonproteolytic activation of prorenin led to significant suppression of ocular inflammation in endotoxin-induced uveitis. The purpose of the present study was to investigate whether nonproteolytically activated prorenin plays a role in ischemia-induced retinal neovascularization.

METHODS. C57BL/6 neonatal mice were reared in an 80% concentration of oxygen from postnatal (P) day 7 to P12, followed by room-air breathing to P17 to induce ischemia-initiated retinal neovascularization. Tissue localization of activated prorenin and prorenin receptor was examined by immunohistochemistry. Animals received intraperitoneal injections of handle-region peptide (HRP), a decoy peptide corresponding to the handle region of prorenin, which inhibits prorenin receptor-mediated upregulation of the renin-angiotensin system (RAS). A concanavalin A lectin perfusion-labeling technique was used to evaluate the areas of physiologic and pathologic retinal new vessels and the number of leukocytes adhering to the vasculature. Retinal mRNA expression and protein levels of intercellular adhesion molecule (ICAM)-1, vascular endothelial growth factor (VEGF), VEGF receptor (VEGFR)-1, and VEGFR-2 were examined by RT-PCR and ELISA.

RESULTS. Retinal vessels in ischemic retinopathy eyes were positive for activated prorenin and prorenin receptor. Pathologic, but not physiologic, retinal neovascularization was significantly attenuated in HRP-treated mice compared with vehicle- or control peptide-treated animals. The number of adherent leukocytes was also significantly reduced. Retinal mRNA expression and protein levels of ICAM-1, VEGF, VEGFR-1, and VEGFR-2 in ischemic retinopathy were also significantly suppressed by the application of HRP.

CONCLUSIONS. The present findings suggest that nonproteolytic activation of prorenin selectively promotes pathologic, but not physiologic, retinal neovascularization through the inflammatory processes related to pathologic neovascularization.




This article has been cited by other articles:


Home page
 Exp PhysiolHome page
Z. Shan, A. E. Cuadra, C. Sumners, and M. K. Raizada
Characterization of a functional (pro)renin receptor in rat brain neurons
Exp Physiol, May 1, 2008; 93(5): 701 - 708.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
G. Nguyen and A. H. J. Danser
Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents
Exp Physiol, May 1, 2008; 93(5): 557 - 563.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. J. Campbell
Critical Review of Prorenin and (Pro)renin Receptor Research
Hypertension, May 1, 2008; 51(5): 1259 - 1264.
[Full Text] [PDF]

Home page
 IOVSHome page
N. Nagai, K. Izumi-Nagai, Y. Oike, T. Koto, S. Satofuka, Y. Ozawa, K. Yamashiro, M. Inoue, K. Tsubota, K. Umezawa, et al.
Suppression of Diabetes-Induced Retinal Inflammation by Blocking the Angiotensin II Type 1 Receptor or Its Downstream Nuclear Factor-{kappa}B Pathway
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4342 - 4350.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association for Research in Vision and Ophthalmology